Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by newcomer21on Oct 26, 2005 11:08am

349 Views

Post# 9768777

Dr. Friesen

I take from your response that you enjoy stirring the pot on the board and that has some value when companies are missing their targets and apparently dropping the ball. MPH is steadily achieving the milestones they identified. They released the results from Phase II/III in late summer as promised. Summer ends on Sept 22. They announced that further results will be released in fall - so far so good. If you wish to retain your credibility on the board may I suggest that you be objective in your criticism of MPH and less reactive? newcomer21

Bullboard Posts

This junior mining stock offers billions in market exposure